BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32535539)

  • 21. IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia.
    Sarra M; Caruso R; Cupi ML; Monteleone I; Stolfi C; Campione E; Diluvio L; Mazzotta A; Botti E; Chimenti S; Costanzo A; MacDonald TT; Pallone F; Monteleone G
    J Immunol; 2011 May; 186(9):5435-42. PubMed ID: 21441456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2'-fucosyllactose inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response via the STAT3 signaling pathway.
    Lei K; Wang D; Lin L; Zeng J; Li Y; Zhang L; Lane JA; Zuo D; Sun L
    Int Immunopharmacol; 2020 Aug; 85():106659. PubMed ID: 32544868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mild electrical stimulation with heat shock reduces inflammatory symptoms in the imiquimod-induced psoriasis mouse model.
    Tsurekawa Y; Morita M; Suico MA; Moriuchi M; Nakano Y; Piruzyan M; Takada M; Fukami S; Shuto T; Kai H
    Exp Dermatol; 2018 Oct; 27(10):1092-1097. PubMed ID: 29928760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A protective role of complement component 3 in T cell-mediated skin inflammation.
    Purwar R; Bäumer W; Niebuhr M; Tschernig T; Kietzmann M; Werfel T
    Exp Dermatol; 2011 Sep; 20(9):709-14. PubMed ID: 21569105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical Denervation in the Imiquimod-Induced Psoriasiform Mouse Model.
    Onderdijk AJ; Hekking-Weijma IM; Florencia EF; Prens EP
    Methods Mol Biol; 2017; 1559():75-81. PubMed ID: 28063038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-17-Secreting γδ T Cells Are Completely Dependent upon CCR6 for Homing to Inflamed Skin.
    Campbell JJ; Ebsworth K; Ertl LS; McMahon JP; Newland D; Wang Y; Liu S; Miao Z; Dang T; Zhang P; Charo IF; Singh R; Schall TJ
    J Immunol; 2017 Nov; 199(9):3129-3136. PubMed ID: 28972090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
    Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
    J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
    Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
    J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyk2 is a therapeutic target for psoriasis-like skin inflammation.
    Ishizaki M; Muromoto R; Akimoto T; Sekine Y; Kon S; Diwan M; Maeda H; Togi S; Shimoda K; Oritani K; Matsuda T
    Int Immunol; 2014 May; 26(5):257-67. PubMed ID: 24345760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon-Alpha Induces Psoriatic Inflammation in Mice by Phosphorylating FOXO3.
    Gu H; Wang X; Lu M; Wang Y; Ren K; Zhang Y; Liu W; Hu G; Zeng W; Xia Y
    J Interferon Cytokine Res; 2024 Jun; 44(6):260-270. PubMed ID: 38563809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p38α signaling in Langerhans cells promotes the development of IL-17-producing T cells and psoriasiform skin inflammation.
    Zheng T; Zhao W; Li H; Xiao S; Hu R; Han M; Liu H; Liu Y; Otsu K; Liu X; Huang G
    Sci Signal; 2018 Mar; 11(521):. PubMed ID: 29535261
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Fujii K; Yamamoto Y; Mizutani Y; Saito K; Seishima M
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752186
    [No Abstract]   [Full Text] [Related]  

  • 33. Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Regulates Epidermal Keratinization under Psoriatic Skin Inflammation.
    Ogawa T; Ishitsuka Y; Inoue S; Nakamura Y; Saito A; Okiyama N; Fujisawa Y; Furuta J; Watanabe R; Fujimoto M
    Am J Pathol; 2020 Mar; 190(3):577-585. PubMed ID: 31953037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory Effect of Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice by Histamine H4 Receptor Agonist 4-Methylhistamine.
    Kim CH; Lee JM; Yoo JK; Kim JS; Kim SU; Chang KT; Choo YK
    Scand J Immunol; 2016 Jun; 83(6):409-17. PubMed ID: 26900758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-inflammatory effects of a methanol extract of Dictamnus dasycarpus Turcz. root bark on imiquimod-induced psoriasis.
    Choi M; Yi JK; Kim SY; Ryu JH; Lee J; Kwon W; Jang S; Kim D; Kim M; Kim H; Kim SH; Choi SK; Ryoo ZY
    BMC Complement Altern Med; 2019 Dec; 19(1):347. PubMed ID: 31791315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Esculetin Ameliorates Psoriasis-Like Skin Disease in Mice by Inducing CD4
    Chen Y; Zhang Q; Liu H; Lu C; Liang CL; Qiu F; Han L; Dai Z
    Front Immunol; 2018; 9():2092. PubMed ID: 30258447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paeoniflorin inhibits skin lesions in imiquimod-induced psoriasis-like mice by downregulating inflammation.
    Sun Y; Zhang J; Huo R; Zhai T; Li H; Wu P; Zhu X; Zhou Z; Shen B; Li N
    Int Immunopharmacol; 2015 Feb; 24(2):392-399. PubMed ID: 25576402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.
    Morimura S; Oka T; Sugaya M; Sato S
    J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-38 Ameliorates Skin Inflammation and Limits IL-17 Production from γδ T Cells.
    Han Y; Mora J; Huard A; da Silva P; Wiechmann S; Putyrski M; Schuster C; Elwakeel E; Lang G; Scholz A; Scholz T; Schmid T; de Bruin N; Billuart P; Sala C; Burkhardt H; Parnham MJ; Ernst A; Brüne B; Weigert A
    Cell Rep; 2019 Apr; 27(3):835-846.e5. PubMed ID: 30995480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of MyD88 signaling in the imiquimod-induced mouse model of psoriasis: focus on innate myeloid cells.
    Costa S; Marini O; Bevilacqua D; DeFranco AL; Hou B; Lonardi S; Vermi W; Rodegher P; Panato A; Tagliaro F; Lowell CA; Cassatella MA; Girolomoni G; Scapini P
    J Leukoc Biol; 2017 Sep; 102(3):791-803. PubMed ID: 28642279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.